Galera therapeutics, inc. appoints christopher degnan as chief financial officer, effective october 21, 2019

Galera therapeutics, inc. announced that christopher degnan has been named chief financial officer, effective october 21, 2019. mr. degnan recently served as chief financial officer at verrica pharmaceuticals.

GRTX Ratings Summary

GRTX Quant Ranking